Address
Form of work
SalaryBenefits:
Company Overview:
Avalyn Pharma is developing innovative, inhaled therapies to target the lungs for treatment of rare respiratory diseases, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Avalyn completed an oversubscribed $175M Series C financing in September 2023 to advance our clinical-stage pulmonary fibrosis portfolio consisting of inhaled pirfenidone (AP01), inhaled nintedanib (AP02), and a fixed-dose combination of both (AP03). Currently, treatment for IPF and PPF includes the oral antifibrotics, pirfenidone and nintedanib. Due to side effects, 30-50% of patients cannot tolerate these medications. Avalyn has developed inhaled formulations for these FDA-approved antifibrotics. AP01 has now been studied in over 150 patients with various forms of pulmonary fibrosis, over at least 48 weeks and some out to 4 years and is phase 2b ready. PK studies show that AP01 reaches 35 times the concentration in the lung with 1/15th of the systemic concentration compared to historic oral pirfenidone. AP01 has demonstrated efficacy in the ATLAS study, with a high dose achieving near stabilization of lung function and is well tolerated with fewer systemic adverse events vs. historic oral pirfenidone. We have also completed a phase 1a study of AP02, an inhaled formulation of nintedanib, with phase 1b & 2 plans being developed. Phase 1a positive topline results were announced in March 2023, and AP02 was demonstrated to be safe and well tolerated in normal volunteers & IPF patients in that study.
Position Overview:
We are seeking a dynamic and experienced pharmaceutical professional to join our team as Associate Director, Corporate Development to support the successful strategic planning and tactical execution of our corporate strategy through corporate affairs, corporate communication, financing support, and business development. This position will report to the SVP, Business Operations and work closely with the CEO and CFO of Avalyn.
Key Responsibilities:
Investor Relations (IR)
o Develop and update investor presentations.
o Maintain Investor & Banking contact databases, investor interaction notes, and calendars.
o Serve as the primary point of contact within Avalyn to coordinate responses to investor questions, leading cross-functional team to respond to diligence questions
o Lead organization of all investor events for CEO and CFO, including in-person and online conferences, investor presentation materials, and calendars for 1 on 1 meeting scheduling.
o Help organize and support investor roadshows.
o Organize and lead execution of IR tactics
o Align with IR vendor on IR strategy.
Public Relations (PR) and Communications
o Direct / align with PR vendor on PR strategy and press releases.
o Respond to requests for information from the media.
o Ensure timely development of all press release workstreams.
o Develop PR strategies and monitor external environment .
o Update and maintain Avalyn’s digital content, including website and social media.
o In partnership with the Medical Affairs team, plan all medical/scientific conferences.
o Manage corporate affairs conference planning .
Business Development (BD)
o Build and maintain strong relationships with potential strategic partners in the US, Europe and other relevant regions.
o Identify potential molecules and products of interest as potential pipeline assets, and work with team to lead internal assessments.
o Plan, track and lead all BD analyses and interactions.
o Attend and represent the company on BD matters at industry conferences and meetings.
The ideal candidate for this role will have:
- 401(k) matching
- Bonus based on performance
- Competitive salary
- Health insurance
- Opportunity for advancement
- Paid time off
- Parental leave
- Stock options plan
- Vision insurance
- Wellness resources
Company Overview:
Avalyn Pharma is developing innovative, inhaled therapies to target the lungs for treatment of rare respiratory diseases, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Avalyn completed an oversubscribed $175M Series C financing in September 2023 to advance our clinical-stage pulmonary fibrosis portfolio consisting of inhaled pirfenidone (AP01), inhaled nintedanib (AP02), and a fixed-dose combination of both (AP03). Currently, treatment for IPF and PPF includes the oral antifibrotics, pirfenidone and nintedanib. Due to side effects, 30-50% of patients cannot tolerate these medications. Avalyn has developed inhaled formulations for these FDA-approved antifibrotics. AP01 has now been studied in over 150 patients with various forms of pulmonary fibrosis, over at least 48 weeks and some out to 4 years and is phase 2b ready. PK studies show that AP01 reaches 35 times the concentration in the lung with 1/15th of the systemic concentration compared to historic oral pirfenidone. AP01 has demonstrated efficacy in the ATLAS study, with a high dose achieving near stabilization of lung function and is well tolerated with fewer systemic adverse events vs. historic oral pirfenidone. We have also completed a phase 1a study of AP02, an inhaled formulation of nintedanib, with phase 1b & 2 plans being developed. Phase 1a positive topline results were announced in March 2023, and AP02 was demonstrated to be safe and well tolerated in normal volunteers & IPF patients in that study.
Position Overview:
We are seeking a dynamic and experienced pharmaceutical professional to join our team as Associate Director, Corporate Development to support the successful strategic planning and tactical execution of our corporate strategy through corporate affairs, corporate communication, financing support, and business development. This position will report to the SVP, Business Operations and work closely with the CEO and CFO of Avalyn.
Key Responsibilities:
Investor Relations (IR)
o Develop and update investor presentations.
o Maintain Investor & Banking contact databases, investor interaction notes, and calendars.
o Serve as the primary point of contact within Avalyn to coordinate responses to investor questions, leading cross-functional team to respond to diligence questions
o Lead organization of all investor events for CEO and CFO, including in-person and online conferences, investor presentation materials, and calendars for 1 on 1 meeting scheduling.
o Help organize and support investor roadshows.
o Organize and lead execution of IR tactics
o Align with IR vendor on IR strategy.
Public Relations (PR) and Communications
o Direct / align with PR vendor on PR strategy and press releases.
o Respond to requests for information from the media.
o Ensure timely development of all press release workstreams.
o Develop PR strategies and monitor external environment .
o Update and maintain Avalyn’s digital content, including website and social media.
o In partnership with the Medical Affairs team, plan all medical/scientific conferences.
o Manage corporate affairs conference planning .
Business Development (BD)
o Build and maintain strong relationships with potential strategic partners in the US, Europe and other relevant regions.
o Identify potential molecules and products of interest as potential pipeline assets, and work with team to lead internal assessments.
o Plan, track and lead all BD analyses and interactions.
o Attend and represent the company on BD matters at industry conferences and meetings.
The ideal candidate for this role will have:
- Minimum of 4 years of life sciences, pharmaceutical or biotech experience.
- Advanced degree, MBA preferred.
- Experience in biotech corporate strategy, strategy consulting, business development, and/or financing (investment banking / equity capital markets). Candidates that have experience in biotech companies with a recent MBA, candidates from large strategy consulting firms, early career professionals in venture capital firms who seek operational experience, and/or professionals with investment banking experience are especially encouraged to apply.
- High level of independence in a small-company environment, a ‘get things done’ attitude, and ability to quickly recognize the need to seek advice from internal and external experts.
- Ability to develop and maintain a budget and deploy resources effectively and efficiently.
- Experience working collaboratively cross-functionally, including with clinical development, medical affairs, commercial, communications/corporate affairs or finance colleagues.
- Excellent communication skills and capable of learning Avalyn’s business strategies and articulating to wide audiences including key external stakeholders.
- Competence in planning tasks, organizing information and solving problems.
- Willingness to learn and be receptive to constructive feedback.
- Knowledge in drug development or business development of respiratory or pulmonary therapies, inhaled products or combination (drug/device) products.
This is a remote position.
